[AMRX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -18.75%
YoY- 505.10%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 702,468 620,040 545,557 528,593 519,294 378,283 476,487 6.67%
PBT 15,423 22,957 2,180 -2,043 -21,889 26,276 22,574 -6.14%
Tax 3,666 -2,076 4,570 4,049 144 389,668 5,109 -5.37%
NP 11,757 9,682 -2,390 -4,237 -8,975 -265,006 6,952 9.14%
Tax Rate -23.77% 9.04% -209.63% - - -1,482.98% -22.63% -
Total Cost 690,711 610,358 547,947 532,830 528,269 643,289 469,535 6.63%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 1.67 1.56 -0.44 -0.80 -1.73 -70.05 1.46 2.26%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.04 0.06 -0.02 -0.03 -0.06 -2.03 0.05 -3.64%
EPS Diluted 0.04 0.06 -0.02 -0.03 -0.06 -2.03 0.05 -3.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.